Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03375645 · ClinicalTrials.gov registry record
Montefiore Opioid and Pain Study
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 462
- Enrollment target
NCT03375645: Completed study, sponsored by Montefiore Medical Center.
NCT03375645 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 462 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03375645 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 462 participants
- Enrollment target
Study Summary
This study will determine pain and opioid outcomes 3 \& 6 months after an emergency department visit for acute pain. This is an observational study. Patients are enrolled during an ED visit and followed by telephone 3 \& 6 months later. Opioid databases will also be reviewed.
Primary Outcome
All participants in this study received an opioid prescription at the time of discharge from the emergency department. Using a review of a prescription monitoring database, this study will determine whether participants received a subsequent prescription for an opioid medication.
Interventions
- DRUG Any oral opioid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 462 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2022-02-15 |
What the finished NCT03375645 record still lists
NCT03375645 is an observational study that tracks outcomes without assigning an intervention. The registered 462 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Any oral opioid is the first listed.
NCT03375645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03375645 about?
NCT03375645 is a clinical study titled "Montefiore Opioid and Pain Study". This study will determine pain and opioid outcomes 3 \& 6 months after an emergency department visit for acute pain. This is an observational study. Patients are enrolled during an ED visit and followed by telephone 3 \& 6 months later. Opioid databases will also be reviewed.
What is the current status of trial NCT03375645?
This trial is currently completed. The enrollment target is 462 participants. The study started on 2017-11-08. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT03375645?
The interventions under investigation include: Any oral opioid (DRUG).
Who is sponsoring clinical trial NCT03375645?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00949819 · 462 participants
Active Surveillance for Cancer of the Prostate (ASCaP)
- NCT05126277 · 462 participants · Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
- NCT04546399 · 461 participants · Phase 2
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI